Natural killer cells as a promising therapeutic target for cancer immunotherapy

N Kim, HH Lee, HJ Lee, WS Choi, J Lee… - Archives of pharmacal …, 2019 - Springer
Natural killer (NK) cells are innate lymphoid cells that provide early protection against
cancer development via their selectivity to kill abnormal cells undergoing cellular …

Natural killer cells as a promising therapeutic target for cancer immunotherapy

NY Kim, HH Lee, HJ Lee, WS Choi… - Archives of …, 2019 - oldkmbase.medric.or.kr
Natural killer (NK) cells are innate lymphoid cells that provide early protection against
cancer development via their selectivity to kill abnormal cells undergoing cellular …

Natural killer cells as a promising therapeutic target for cancer immunotherapy.

N Kim, HH Lee, HJ Lee, WS Choi, J Lee… - Archives of Pharmacal …, 2019 - europepmc.org
Natural killer (NK) cells are innate lymphoid cells that provide early protection against
cancer development via their selectivity to kill abnormal cells undergoing cellular …

Natural killer cells as a promising therapeutic target for cancer immunotherapy.

N Kim, HH Lee, HJ Lee, WS Choi… - Archives of …, 2019 - search.ebscohost.com
Natural killer (NK) cells are innate lymphoid cells that provide early protection against
cancer development via their selectivity to kill abnormal cells undergoing cellular …

Natural killer cells as a promising therapeutic target for cancer immunotherapy

N Kim, HH Lee, HJ Lee, WS Choi… - Archives of …, 2019 - pubmed.ncbi.nlm.nih.gov
Natural killer (NK) cells are innate lymphoid cells that provide early protection against
cancer development via their selectivity to kill abnormal cells undergoing cellular …

Natural killer cells as a promising therapeutic target for cancer immunotherapy

NY Kim, HH Lee, HJ Lee, WS Choi… - Archives of …, 2019 - oldkmbase.medric.or.kr
Natural killer (NK) cells are innate lymphoid cells that provide early protection against
cancer development via their selectivity to kill abnormal cells undergoing cellular …

[引用][C] Natural killer cells as a promising therapeutic target for cancer immunotherapy

N Kim, HH Lee, HJ Lee, WS Choi, J Lee, HS Kim - 2019